Case report: HLA-haploidentical hematopoietic cell transplant with posttransplant cyclophosphamide in a patient with leukocyte adhesion deficiency type I.
graft-versus-host disease
hematopoietic cell transplantation
inborn errors of immunity
leukocyte adhesion deficiency
posttransplant cyclophosphamide
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2022
2022
Historique:
received:
16
08
2022
accepted:
30
09
2022
entrez:
10
11
2022
pubmed:
11
11
2022
medline:
15
11
2022
Statut:
epublish
Résumé
Leukocyte adhesion deficiency type I (LAD-I) is a rare autosomal recessive inborn error of immunity (IEI) caused by the defects in CD18, encoded by the
Identifiants
pubmed: 36353617
doi: 10.3389/fimmu.2022.1020362
pmc: PMC9638093
doi:
Substances chimiques
Cyclophosphamide
8N3DW7272P
HLA Antigens
0
Types de publication
Case Reports
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1020362Informations de copyright
Copyright © 2022 Yamashita, Eguchi, Tomomasa, Kamiya, Niizato, Mitsuiki, Isoda, Funakoshi, Mizuno, Okamoto, Nguyen, Takada, Takagi, Imai, Morio and Kanegane.
Déclaration de conflit d'intérêts
The handling editor HM declared a past co-authorship with the author HK. The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Blood. 2008 Sep 15;112(6):2591
pubmed: 18779414
Front Pediatr. 2019 Oct 24;7:436
pubmed: 31709206
Front Immunol. 2021 Feb 25;12:648951
pubmed: 33717203
Hum Mutat. 1993;2(6):458-67
pubmed: 7509236
Blood. 2015 Apr 30;125(18):2865-74
pubmed: 25736310
Bone Marrow Transplant. 2018 Feb;53(2):138-145
pubmed: 28759025
J Pediatr Hematol Oncol. 2018 Mar;40(2):137-140
pubmed: 29324573
Nat Med. 2009 Mar;15(3):313-8
pubmed: 19234460
Pediatr Blood Cancer. 2018 Jan;65(1):
pubmed: 28901730
Blood. 2015 Apr 30;125(18):2855-64
pubmed: 25742699
Pediatrics. 2009 Mar;123(3):836-40
pubmed: 19255011
Biol Blood Marrow Transplant. 2019 Jul;25(7):1363-1373
pubmed: 30876929
Blood Adv. 2021 Jan 12;5(1):262-273
pubmed: 33570653
Biol Blood Marrow Transplant. 2020 Oct;26(10):1923-1929
pubmed: 32653621
J Clin Immunol. 2021 Nov;41(8):1754-1761
pubmed: 34355352
J Allergy Clin Immunol Pract. 2018 Jul - Aug;6(4):1418-1420.e10
pubmed: 29371071
Bone Marrow Transplant. 2015 Feb;50(2):317-9
pubmed: 25419693
Blood. 1995 Aug 15;86(4):1629-35
pubmed: 7632973
Front Immunol. 2020 Dec 16;11:612703
pubmed: 33391282
Sci Transl Med. 2013 Nov 13;5(211):211ra157
pubmed: 24225944
Biol Blood Marrow Transplant. 2020 Nov;26(11):e286-e291
pubmed: 32798657
Front Immunol. 2022 Jan 10;12:805766
pubmed: 35082792
Nat Genet. 2001 May;28(1):73-6
pubmed: 11326280
Haematologica. 2022 Apr 01;107(4):857-867
pubmed: 33832208
Ann Hematol. 2019 Oct;98(10):2425-2426
pubmed: 31375859
Bone Marrow Transplant. 2021 Sep;56(9):2052-2062
pubmed: 34226669
J Clin Exp Hematop. 2021 Mar 18;61(1):1-9
pubmed: 33551435
J Clin Invest. 2019 Mar 26;129(6):2357-2373
pubmed: 30913039